Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

OBJECTIVES: To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid arthritis (RA). METHODS: AMPLE is a phase IIIb, 2-year, randomised, investigator-blinded study with a 1-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiff, Michael, Weinblatt, Michael E, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Elegbe, Ayanbola, Maldonado, Michael, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888617/
https://www.ncbi.nlm.nih.gov/pubmed/23962455
http://dx.doi.org/10.1136/annrheumdis-2013-203843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888617/
https://www.ncbi.nlm.nih.gov/pubmed/23962455
http://dx.doi.org/10.1136/annrheumdis-2013-203843

Ejemplares similares